CIK 0001551306
- Large accelerated filer
Progyny, Inc.
Sign in to watch- Ticker
- PGNY
- Exchange
- Nasdaq
- Industry
- Services-Misc Health & Allied Services, NEC
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 272220139
- Phone
- +1 212-888-3124
- Business address
- 1359 BROADWAY, 2ND FLOOR, NEW YORK, NY, 10018
- Former names
- Auxogyn, Inc., Auxogyn Inc
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $22,674,844
- in 10 filings, $22.0M under 10b5-1 plans
Net −$22,674,844. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2023-02-02 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +32,000 | $3.95 | $126K | 255,900 |
| 2023-02-02 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −23,019 | $36.18 | $833K | 232,881 |
| 2023-02-02 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −8,981 | $36.86 | $331K | 223,900 |
| 2023-02-02 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −5,755 | $36.18 | $208K | 142,659 |
| 2023-02-02 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −2,245 | $36.86 | $83K | 140,414 |
| 2023-02-02 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) | −32,000 | 1,290,820 | ||
| 2023-02-02 | Schlanger David J Executive Chairman | Exercise or conversion | +100,000 | $0.91 | $91K | 176,168 |
| 2023-02-02 | Schlanger David J Executive Chairman | Sale | −61,048 | $36.12 | $2.2M | 115,120 |
| 2023-02-02 | Schlanger David J Executive Chairman | Sale | −38,952 | $36.79 | $1.4M | 76,168 |
| 2023-02-02 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) | −100,000 | 1,030,943 | ||
| 2023-02-01 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +32,000 | $3.95 | $126K | 255,093 |
| 2023-02-01 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −32,000 | $35.14 | $1.1M | 223,093 |
| 2023-02-01 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −8,000 | $35.14 | $281K | 148,414 |
| 2023-02-01 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion · Stock Option (Right to Buy) | −32,000 | 1,322,820 | ||
| 2023-02-01 | Schlanger David J Executive Chairman | Exercise or conversion | +100,000 | $0.91 | $91K | 174,716 |
| 2023-02-01 | Schlanger David J Executive Chairman | Sale | −100,000 | $35.18 | $3.5M | 74,716 |
| 2023-02-01 | Schlanger David J Executive Chairman | Exercise or conversion · Stock Option (Right to Buy) | −100,000 | 1,132,395 | ||
| 2023-01-31 | Anevski Peter CHIEF EXECUTIVE OFFICER | Exercise or conversion | +735 | $3.95 | $3K | 223,828 |
| 2023-01-31 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −735 | $35.00 | $26K | 223,093 |
| 2023-01-31 | Anevski Peter CHIEF EXECUTIVE OFFICER | Sale | −184 | $35.00 | $6K | 156,414 |
Page 32 of 77 · 1,524 trades